Heterogeneity of acute myeloblastic leukemia without maturation: an ultrastructural study. 1995

K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.

We demonstrated by ultrastructural examination that the leukemic blasts of 13 patients with acute myeloblastic leukemia (AML) without maturation (M1 in the French-American-British classification) showed heterogeneous features. In 7 patients, the leukemic blasts had a high level of light microscopic myeloperoxidase positivity (> 50%). Ultrastructurally, the cells were myeloblast-promyelocytes with 100% myeloperoxidase positivity, and these 7 patients appeared to have typical AML. In contrast, the remaining 6 patients had leukemic blasts with a low myeloperoxidase positivity (< 50%) and heterogeneous features. Three had ultrastructural features of myelomonocytic or monocytic lineage, 1 had myelomonocytic cells associated with megakaryoblasts, and 1 had undifferentiated blasts. The former group had a better prognosis than the latter, indicating that ultrastructural analysis of M1 leukemia may help predict the response to therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151

Related Publications

K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
December 1988, Leukemia,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
April 1994, Sangre,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
January 1989, Hematologic pathology,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
February 1985, The Journal of clinical investigation,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
January 2006, The Journal of veterinary medical science,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
February 2015, World journal of gastroenterology,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
January 2003, Annales de biologie clinique,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
May 1978, Virchows Archiv. B, Cell pathology,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
August 1980, Problemy gematologii i perelivaniia krovi,
K Hamamoto, and M Date, and H Taniguchi, and T Nagano, and Y Kishimoto, and T Kimura, and S Fukuhara
April 1950, La Semana medica,
Copied contents to your clipboard!